Cerner Rises on Partnership Deal - Analyst Blog

By
A A A
Share |

Shares of Cerner Corp. ( CERN ) rose nearly 8% following the announcement of a multiyear partnership with Intermountain Healthcare. It was close to the 52-week high of $55.07.

Intermountain is a Utah-based non-profit health care provider. It has 22 hospitals, 185 clinics, a medical group comprising 1,000 physicians and a health plans division. The partnership agreement will implement Cerner's electronic medical record and revenue cycle solutions across all of Intermountain's hospitals and clinics.

The partnership will also develop a new set of tools for a post-fee-for-service world in areas such as activity-based costing. As per the agreement, staffs from Cerner will relocate to Salt Lake City, Utah and work with Cerner Intermountain's executives. The partnership is expected to generate more than $50 million in annual revenue to CERN.

Cerner reported a 14.3% rise in second-quarter 2013 earnings per share to 32 cents, meeting the Zacks Consensus Estimate. Net income rose 15.4% year over year to $112.9 million.

Revenues in the quarter rose 11.0% year over year to $707.6 million. However, it missed the Zacks Consensus Estimate of $724 million. The sales growth was at the lower end of Cerner's earlier assumptions due to reduced volume of tech resale, which carries a lower margin.

For the third quarter of 2013, CERN forecasts sales in a band of $740 million-$770 million. Earnings per share, before share based compensation expense, are expected in the range of 35 cents to 36 cents. Cerner projects stock-based compensation costs to dilute second quarter earnings by about 2 cents to 3 cents.

For 2013, the company continues to forecast sales in the region of $2,950 million to $3,050 million. Earnings per share, before share-based compensation expense, are forecasted in the range of $1.40 and $1.42 (earlier $1.39 and $1.42). Cerner projects stock-based compensation costs to dilute earnings by about 8 cents to 9 cents.

Currently, Cerner carries a Zacks Rank #3 (Hold). Other medical information systems stocks that are worth a look include Streamline Health Solutions, Inc. ( STRM ) with a Zacks Rank #2 (Buy). These apart, we consider medical product stocks such as Alere Inc. ( ALR ) with a Zacks Rank #1 (Strong Buy) and Boston Scientific Corp. ( BSX ) with a Zacks Rank #2 (Buy).



ALERE INC (ALR): Free Stock Analysis Report

BOSTON SCIENTIF (BSX): Free Stock Analysis Report

CERNER CORP (CERN): Free Stock Analysis Report

STREAMLINE HLTH (STRM): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: ALR , BSX , CERN , STRM

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

152,099,280
  • $16.13 ▼ 1.59%
76,450,549
  • $59.72 ▲ 1.07%
57,375,391
  • $36.35 ▲ 6.26%
50,140,425
  • $26.93 ▲ 0.60%
49,201,544
  • $3.17 ▲ 2.59%
39,533,031
  • $86.18 ▲ 1.33%
36,760,050
  • $13.42 ▲ 2.84%
33,109,047
  • $26.12 ▲ 1.16%
As of 4/16/2014, 04:05 PM